MRSJX | VTISX | MRSJX / VTISX | |
Total Expense Ratio | 0.73 | 0.05 | 1,553% |
Annual Report Gross Expense Ratio | 0.74 | 0.05 | 1,574% |
Fund Existence | 20 years | 9 years | - |
Gain YTD | 12.572 | 15.938 | 79% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 16.8B | 511B | 3% |
Annual Yield % from dividends | 1.80 | 2.87 | 63% |
Returns for 1 year | 9.67 | 13.60 | 71% |
Returns for 3 years | 32.05 | 33.03 | 97% |
Returns for 5 years | 41.83 | 38.58 | 108% |
Returns for 10 years | 73.02 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IBBQ | 22.40 | 0.13 | +0.57% |
Invesco Nasdaq Biotechnology ETF | |||
XCCC | 38.32 | -0.17 | -0.45% |
BondBloxx CCC Rated USD HY Corp Bd ETF | |||
PRF | 42.04 | -0.56 | -1.31% |
Invesco RAFI US 1000 ETF | |||
OSCV | 35.98 | -0.56 | -1.53% |
Opus Small Cap Value Plus ETF | |||
LRGG | 29.19 | -0.57 | -1.92% |
Macquarie Focused Large Growth ETF |